Zepbound is an injectable medication used for weight loss. Its active ingredient, tirzepatide, works by mimicking natural hormones to help manage appetite and blood sugar. A key effect of Zepbound is that it slows down gastric emptying, meaning it takes longer for food and medications to move from the stomach to the small intestine. While helpful for weight management, this can change how your body absorbs other medications you take by mouth, potentially causing interactions or making other drugs less effective. Always discuss all your current medications, including prescriptions, over-the-counter drugs, and supplements, with your healthcare provider before starting Zepbound.
Diabetes Medications and the Risk of Hypoglycemia
Combining Zepbound with certain diabetes medications can significantly increase the risk of hypoglycemia, or low blood sugar. This is particularly important for those taking insulin or medications that cause the body to release more insulin.
Insulin and Insulin Secretagogues
Patients using insulin will need close monitoring when starting Zepbound. Both drugs lower blood sugar, so taking them together can cause levels to drop too low. Your doctor will likely adjust your insulin dose to reduce this risk. Similarly, drugs called insulin secretagogues, which include sulfonylureas and meglitinides, stimulate the pancreas to produce more insulin. Combining these with Zepbound also raises the risk of severe hypoglycemia.
- Sulfonylureas: Examples include glipizide, glyburide, and glimepiride.
- Meglitinides: Examples include repaglinide and nateglinide.
Other GLP-1 and GIP Agonists
Zepbound itself is a dual GIP and GLP-1 agonist. You should not use Zepbound with other medications that work in a similar way, such as Ozempic or Wegovy (semaglutide) or Mounjaro (also tirzepatide). Combining these can lead to increased side effects like nausea and vomiting.
Oral Contraceptives and Reduced Effectiveness
Because Zepbound slows stomach emptying, it can affect the absorption of oral medications, including birth control pills. This can make oral contraceptives less effective, increasing the risk of unintended pregnancy. The FDA advises using an alternative or barrier method of birth control for at least four weeks after starting Zepbound and after any increase in dosage.
Narrow Therapeutic Index Medications
Medications with a narrow therapeutic index (NTI) require careful monitoring because even small changes in their absorption can lead to serious problems, either making them toxic or ineffective. Due to Zepbound's effect on absorption, caution is needed with NTI drugs. Examples of NTI drugs include warfarin (a blood thinner), digoxin (a heart medication), and levothyroxine (a thyroid hormone replacement). Your doctor may need to monitor levels of these medications more closely if you are taking Zepbound.
Other Oral Medications and Supplements
Zepbound's delayed gastric emptying can impact the absorption of many oral medications, including both prescription and over-the-counter drugs. This effect is usually most noticeable when you first start Zepbound or increase your dose. The absorption of oral antibiotics or pain relievers like ibuprofen could be affected. Additionally, supplements, especially those that can lower blood sugar like ginseng or chromium, should be used with caution due to the potential for increased hypoglycemia risk when combined with Zepbound.
Comparison Table: Key Zepbound Drug Interactions
Medication Class | Examples | Interaction Type | Action/Recommendation |
---|---|---|---|
Insulin | Insulin aspart, glargine | Increased risk of hypoglycemia | Monitor blood glucose closely; healthcare provider may adjust insulin dose. |
Sulfonylureas & Meglitinides | Glipizide, repaglinide | Increased risk of hypoglycemia | Monitor blood glucose; dose may be lowered by a healthcare provider. |
Oral Contraceptives | Ethinyl estradiol/norethindrone | Reduced effectiveness due to delayed absorption | Switch to a non-oral method or use a barrier method for 4 weeks after initiation and dose increase. |
Narrow Therapeutic Index (NTI) Drugs | Warfarin, Digoxin | Altered absorption, potential for toxicity or reduced efficacy | Monitor drug levels closely; potential dose adjustments required by healthcare provider. |
Other GLP-1/GIP Agonists | Ozempic, Wegovy, Mounjaro | Overlap in mechanism, increased side effects | Do not use together. Contraindicated. |
Other Oral Medications | Ibuprofen, some antibiotics | Delayed absorption | Monitor effects, especially at treatment start and with dose increases. |
Conclusion
Understanding what medications should not be taken with Zepbound is crucial for safe treatment. There are significant risks, particularly the chance of severe low blood sugar when combined with certain diabetes medications and the potential for other oral drugs, including birth control, to be less effective due to slowed stomach emptying. It is vital to share a complete and current list of all your medications and supplements with your healthcare team. Always consult your doctor before making any changes to your medications and discuss alternative birth control methods if you use oral contraceptives. Taking these steps can help ensure you use Zepbound safely.
For more detailed prescribing information, refer to the official FDA document for Zepbound.